Perfusfind S.L.

Abstract Objective: To assess whether preoperative versus intraoperative insertion of an intra-aortic balloon pump is associated with lower 30-day mortality or reduced length of hospital stay among patients who had..

Perfusfind S.L.

Abstract We conducted a prospective, observational study to determine the incidence of feeding intolerance (FI) within 7 d of initiating enteral nutrition (EN) in patients undergoing cardiopulmonary bypass (CPB) and..

Perfusfind S.L.

Abstract Objectives To explore the preoperative, intraoperative, and postoperative dynamics of heparin-binding protein (HBP) in cardiothoracic surgery. Design This was a prospective, observational study. Setting The study was conducted at..

Perfusfind S.L.

Abstract Objective To assess whether the administration of the ultra-short–acting β-blocker esmolol in cardiac surgery could have a cardioprotective effect that translates into improved postoperative outcomes. Design Single-center, double-blinded, parallel-group..

Perfusfind S.L.

Abstract Purpose of review  To review pathophysiological pathways of immune system response to infections, which may justify mediators removal by extracorporeal blood purification therapies (EBPTs) in critically ill septic patients...

Perfusfind S.L.

This case study reports on a 56-year-old female patient who presented at the Cardiac Center Aarau for elective mitral valve reconstruction/replacement and left atrial appendage occlusion, after she suffered cardiac..

Perfusfind S.L.

This case study reports on a 58-year-old female patient (known pre-existing conditions: very severe COPD (Gold stage IV), encapsulated pleural effusion with suspicion of empyema after left lung volume reduction..

Perfusfind S.L.

This case reports on a 7-month-old male pediatric patient (known pre-existing conditions: trisomy 21 (also known as Downs syndrome), aortic isthmus stenosis, atrioventricular septal defect (AVSD) Rastelli type C), who..

Perfusfind S.L.

This case reports on a 48-year-old male patient who was transferred by air ambulance from a Caribbean island to Hospital Pacifica Salud in Panama due to a stroke, altered consciousness,..

Perfusfind S.L.

This case reports on a 13-year-old male patient who presented to hospital with fever (38.9°), reduced general condition, vomiting and pain in his limbs.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-pediatric-patient-with-severe-rhabdomyolysis-in-the-context-of-a-SARS-CoV-2-infection_compressed.pdf" title="Use of CytoSorb..

Perfusfind S.L.

The case study reports on a 16-year-old girl, who presented to the hospital with syncope and fever (39°C), tachycardia, complaints of chest pain and coughing after fainting at home.  ..

Perfusfind S.L.

This report describes the case of a 59-year-old patient who was transferred from a peripheral hospital for emergency surgery for a type A aortic dissection with paraparesis of the legs,..

Perfusfind S.L.

This case reports on a 31-year-old male patient with no significant medical history, who was hospitalized following several days of non-quantified fever associated with odynophagia.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-severe-COVID-19_compressed.pdf" title="Use of..

Perfusfind S.L.

This case reports on a 79-year-old female patient who presented to the hospital for elective surgery due to severe mitral valve and tricuspid valve insufficiency.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-severe-ARDS-and-septic-shock-after-mitral-valve-and-tricuspid-valve-reconstruction_compressed.pdf" title="Use of..

Perfusfind S.L.

This case reports on a 2-year-old male patient (weight 12 kg), who was admitted to the children‘s outpatient department with anuria, bloody diarrhea, anemia and severe edema (anasarca).   [pdf-embedder..

Perfusfind S.L.

This case reports on a 76-year-old male patient, who was admitted to the emergency department two weeks after an elective and initially complication-free pancreas resection with acute abdomen, signs of..

Perfusfind S.L.

This case study reports on a 59-year-old patient who presented with dyspnea and weight gain of 12 kg at a peripheral hospital.    [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-mitral-valve-dysfunction-atypical-pneumonia-and-mixed-cardiogenic-and-septic-shock_compressed.pdf" title="Use of CytoSorb in a..

Perfusfind S.L.

This case reports on a 58-year-old male patient who was admitted to the South Munich Surgical Clinic for urgent coronary artery bypass surgery.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Ticagrelor-and-Rivaroxaban-Elimination-With-CytoSorb-Adsorber-Before-Urgent-Off-Pump-Coronary-Bypass-_compressed.pdf" title="Ticagrelor and Rivaroxaban Elimination..

Perfusfind S.L.

This case reports on a 23-year-old male patient, who was admitted to the hospital with complaints of dyspnea associated with tiredness, dizziness and chest discomfort.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-undergoing-orthotopic-heart-transplant-surgery-_compressed.pdf" title="Use of..

Perfusfind S.L.

El uso intraoperatorio de CytoSorb en pacientes sometidos a tratamiento con ticagrelor o rivaroxaban que tienen que someterse a una cirugía de emergencia a corazón abierto es un método seguro..

Perfusfind S.L.

Con el uso de Cytosorb los datos clínicos actuales apuntan claramente a una estabilización rápida de la hemodinamia y las funciones orgánicas de los pacientes de cuidados intensivos con síndrome..

Perfusfind S.L.

The intraoperative use of the CytoSorb hemoadsorption in patients with ticagrelor or rivaroxaban treatment undergoing emergency open-heart operations is a safe and effective method to reduce bleeding complications and to..

Perfusfind S.L.

Ticagrelor is a platelet aggregation inhibitor and is recommended in the current European Guidelines for the treatment of acute coronary syndrome and prevention of stent thrombosis.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reduce-bleeding-complications-in-patients-on-ticagrelor_compressed.pdf" title="Reduce..

Perfusfind S.L.

El ticagrelor es un inhibidor de la agregación plaquetaria y se recomienda en las directrices europeas para el tratamiento del síndrome coronario agudo y para la profilaxis de la trombosis..

Perfusfind S.L.

This case study reports on a 69-year-old female patient (pre-existing medical conditions: chronic heart failure NYHA III, Type 2 diabetes mellitus, multiple myeloma, chronic kidney disease stage 3), who was..

Perfusfind S.L.

The following case study reports on a 13-year-old pediatric patient (body weight 45 kg) who was admitted to our hospital due to a deterioration in his clinical condition, after he..

Perfusfind S.L.

This case reports on a 49-year-old previously healthy female patient, who presented to the Accident and Emergency Department of a peripheral hospital with complaints of breathlessness and fever for one..

Perfusfind S.L.

In these patients there is a high chance of success (shock reversal) possibly translating to survival benefits when the adsorber treatment is started in good time.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy_compressed.pdf" title="CytoSorb..

Perfusfind S.L.

Limited treatment options are currently available for critically-ill COVID-19 ICU patients who may experience mortality rates up to 50%.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-Manage-cytokine-storm-in-patients-with-COVID-19_compressed.pdf" title="CytoSorb Therapy Manage cytokine storm in patients with..

Perfusfind S.L.

CytoSorb Therapy was prospectively applied and retrospectively analyzed to the control group, in patients with pneumogenic sepsis and ARDS until shock reversal was achieved   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-enhanced-ECMO_compressed.pdf" title="CytoSorb Therapy enhanced..